This Dopamine D2 receptor red antagonist is a spiperone derivative labeled with a red emitting HTRF fluorescent probe, to be used in the Tag-lite system.
For research use only. Not for use in diagnostic procedures.
Tag-lite receptor binding assays use either a green or a red fluorescent ligand to function. This Dopamine D2 receptor red antagonist is a spiperone derivative labeled with a red emitting HTRF fluorescent probe.
This ligand is best suited for use in the Dopamine D2 and Dopamine D3a receptor binding assays.
Assay Points |
5000
|
---|---|
Assay Target Type |
Fluorescent reagent
|
Assay Technology |
HTRF
|
Brand |
Tag-Lite
|
Quantity |
1
|
Shipping Conditions |
Shipped in Dry Ice
|
Therapeutic Area |
Metabolism/Diabetes
Neuroscience
Oncology & Inflammation
|
Unit Size |
5,000 Assay Points
|
Running a receptor binding assay using Tag-lite is as easy as it can get. Simply dispense 10 µL of labeled cells into each well, followed by 5 µL of labeled ligand and 5 µL of the compound you wish to test. Like all HTRF assays, Tag-lite assays do not require any washing steps. A diagram of the procedure to be followed is given on the right.
A saturation binding assay measures total and non-specific binding for increasing concentrations of ligand under equilibrium conditions. To perform the assay, the fluorescent ligand is titrated into a solution containing a fixed amount of labeled cells and then incubated to equilibrium. The HTRF ratio obtained from this titration is the total binding.
A competitive binding assay is performed to measure the dissociation constant, Ki. To perform the assay, the compound is titrated into a solution containing a fixed concentration of fluorescent ligand and a fixed amount of cells.
This guide provides you an overview of HTRF applications in several therapeutic areas.
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
We are here to answer your questions.